Microbiology Department, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
J Virol. 2010 Nov;84(21):11255-63. doi: 10.1128/JVI.00947-10. Epub 2010 Aug 18.
Culturing newly identified human lung pathogens from clinical sample isolates can represent a daunting task, with problems ranging from low levels of pathogens to the presence of growth suppressive factors in the specimens, compounded by the lack of a suitable tissue culture system. However, it is critical to develop suitable in vitro platforms to isolate and characterize the replication kinetics and pathogenesis of recently identified human pathogens. HCoV-HKU1, a human coronavirus identified in a clinical sample from a patient with severe pneumonia, has been a major challenge for successful propagation on all immortalized cells tested to date. To determine if HCoV-HKU1 could replicate in in vitro models of human ciliated airway epithelial cell cultures (HAE) that recapitulate the morphology, biochemistry, and physiology of the human airway epithelium, the apical surfaces of HAE were inoculated with a clinical sample of HCoV-HKU1 (Cean1 strain). High virus yields were found for several days postinoculation and electron micrograph, Northern blot, and immunofluorescence data confirmed that HCoV-HKU1 replicated efficiently within ciliated cells, demonstrating that this cell type is infected by all human coronaviruses identified to date. Antiserum directed against human leukocyte antigen C (HLA-C) failed to attenuate HCoV-HKU1 infection and replication in HAE, suggesting that HLA-C is not required for HCoV-HKU1 infection of the human ciliated airway epithelium. We propose that the HAE model provides a ready platform for molecular studies and characterization of HCoV-HKU1 and in general serves as a robust technology for the recovery, amplification, adaptation, and characterization of novel coronaviruses and other respiratory viruses from clinical material.
从临床样本分离物中培养新鉴定的人类肺部病原体可能是一项艰巨的任务,问题包括病原体水平低、标本中存在生长抑制因子,以及缺乏合适的组织培养系统。然而,开发合适的体外平台来分离和表征新鉴定的人类病原体的复制动力学和发病机制至关重要。HCoV-HKU1 是从一名患有严重肺炎的患者的临床样本中鉴定出的一种人类冠状病毒,迄今为止,在所有经过测试的永生化细胞中,它的成功繁殖一直是一个主要挑战。为了确定 HCoV-HKU1 是否可以在体外模型中复制,该模型模拟了人纤毛气道上皮细胞培养物(HAE)的形态、生物化学和生理学,将 HAE 的顶端表面接种了 HCoV-HKU1(Cean1 株)的临床样本。在接种后几天内发现了高病毒产量,电子显微镜、Northern blot 和免疫荧光数据证实 HCoV-HKU1 在纤毛细胞中有效复制,表明该细胞类型被迄今为止鉴定出的所有人类冠状病毒感染。针对人类白细胞抗原 C(HLA-C)的抗血清未能减弱 HAE 中的 HCoV-HKU1 感染和复制,表明 HLA-C 不是 HCoV-HKU1 感染人纤毛气道上皮所必需的。我们提出,HAE 模型为 HCoV-HKU1 的分子研究和表征提供了一个现成的平台,并且通常可以作为从临床材料中恢复、扩增、适应和表征新型冠状病毒和其他呼吸道病毒的强大技术。